Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy
Background: Rifampicin is one of the important components in the multidrug therapy (MDT)-World Health Organization regimen for leprosy. Clarithromycin is one of the alternative therapies of rifampicin. Methods: This clinical pilot study was to compare the efficacy of 2,000 mg clarithromycin to 600 m...
Main Authors: | Hendra Gunawan, Muljaningsih Sasmojo, Helena Eka Putri, Erda Avriyanti, Reti Hindritiani, Oki Suwarsa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=2;spage=152;epage=155;aulast=Gunawan |
Similar Items
-
Frequent testicular involvement in multibacillary leprosy
by: Hendra Gunawan, et al.
Published: (2020-01-01) -
Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial
by: Daiane Santos dos Santos, et al.
Published: (2018-04-01) -
Unusual Presentation of Multibacillary Nodular Leprosy
by: Shweta Raut, et al.
Published: (2017-01-01) -
The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission
by: Duane C. Hinders, et al.
Published: (2024-02-01) -
Increased expression of interleukin-17A in the lesional skin indicates increase of serum antibody anti-phenolic glycolipid-I in leprosy patients
by: Hendra Gunawan, et al.
Published: (2017-01-01)